These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 12668510

  • 1. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.
    Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM, CAPTURE Study Investigators.
    Circulation; 2003 Apr 29; 107(16):2109-14. PubMed ID: 12668510
    [Abstract] [Full Text] [Related]

  • 2. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML, Zeiher AM, CAPTURE Study Investigators.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):229-37. PubMed ID: 15653020
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome.
    Chalikias GK, Tziakas DN, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris AX, Hatseras DI.
    Int J Cardiol; 2007 May 02; 117(3):333-9. PubMed ID: 16859776
    [Abstract] [Full Text] [Related]

  • 4. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J, Hellmann I, Maass M, Giannitsis E, Dalhoff K, Katus HA.
    Herz; 2004 Dec 02; 29(8):795-801. PubMed ID: 15599677
    [Abstract] [Full Text] [Related]

  • 5. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD, Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators.
    Circulation; 2004 Nov 16; 110(20):3206-12. PubMed ID: 15533869
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators.
    Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173
    [Abstract] [Full Text] [Related]

  • 7. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome.
    Kilic T, Ural D, Ural E, Yumuk Z, Agacdiken A, Sahin T, Kahraman G, Kozdag G, Vural A, Komsuoglu B.
    Heart; 2006 Aug 27; 92(8):1041-6. PubMed ID: 16547209
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM, Camargo PV, Borges FK, Rossini AP, Polanczyk CA.
    Coron Artery Dis; 2010 May 27; 21(3):129-36. PubMed ID: 20305551
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes.
    Oltrona L, Ottani F, Galvani M, Italian Working Group on Atherosclerosis, Thrombosis, and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO).
    Am Heart J; 2004 Sep 27; 148(3):405-15. PubMed ID: 15389226
    [Abstract] [Full Text] [Related]

  • 10. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators.
    Circulation; 2003 Sep 30; 108(13):1560-6. PubMed ID: 12975259
    [Abstract] [Full Text] [Related]

  • 11. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
    Hartford M, Wiklund O, Mattsson Hultén L, Persson A, Karlsson T, Herlitz J, Caidahl K.
    J Intern Med; 2007 Nov 30; 262(5):526-36. PubMed ID: 17908161
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
    Frasure-Smith N, Lespérance F, Irwin MR, Sauvé C, Lespérance J, Théroux P.
    Biol Psychiatry; 2007 Aug 15; 62(4):302-8. PubMed ID: 17210140
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
    Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX, Hatseras DI, Kaski JC.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2471-81. PubMed ID: 17174184
    [Abstract] [Full Text] [Related]

  • 18. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC, Lima JC, Rocha MS, D'Oliveira Junior A, Péricles Esteves J.
    Clin Chim Acta; 2007 Jan 19; 375(1-2):124-8. PubMed ID: 16916502
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting.
    Patti G, Di Sciascio G, D'Ambrosio A, Dicuonzo G, Abbate A, Dobrina A.
    Catheter Cardiovasc Interv; 2002 Jul 19; 56(3):341-5. PubMed ID: 12112886
    [Abstract] [Full Text] [Related]

  • 20. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.
    Indian Heart J; 2008 Jul 19; 60(6):536-42. PubMed ID: 19276492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.